The Nucleotide-Binding Oligomerization Domain-Like Receptor NLRC5 Is Involved in IFN-Dependent Antiviral Immune Responses
Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular patterns or other cytosolic danger signals. Mutations in NLR genes have been linked to a variety of inflammatory diseases, underscoring thei...
Saved in:
Published in | The Journal of immunology (1950) Vol. 184; no. 4; pp. 1990 - 2000 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Am Assoc Immnol
15.02.2010
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-1767 1550-6606 1550-6606 |
DOI | 10.4049/jimmunol.0900557 |
Cover
Abstract | Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular patterns or other cytosolic danger signals. Mutations in NLR genes have been linked to a variety of inflammatory diseases, underscoring their pivotal role in host defense and immunity. This report describes the genomic organization and regulation of the human NLR family member NLRC5 and aspects of cellular function of the encoded protein. We have analyzed the tissue-specific expression of NLRC5 and have characterized regulatory elements in the NLRC5 promoter region that are responsive to IFN-γ. We show that NLRC5 is upregulated in human fibroblasts postinfection with CMV and demonstrate the role of a JAK/STAT-mediated autocrine signaling loop involving IFN-γ. We demonstrate that overexpression and enforced oligomerization of NLRC5 protein results in activation of the IFN-responsive regulatory promoter elements IFN-γ activation sequence and IFN-specific response element and upregulation of antiviral target genes (e.g., IFN-α, OAS1, and PRKRIR). Finally, we demonstrate the effect of small interfering RNA-mediated knockdown of NLRC5 on a target gene level in the context of viral infection. We conclude that NLRC5 may represent a molecular switch of IFN-γ activation sequence/IFN-specific response element signaling pathways contributing to antiviral defense mechanisms. |
---|---|
AbstractList | Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular patterns or other cytosolic danger signals. Mutations in NLR genes have been linked to a variety of inflammatory diseases, underscoring their pivotal role in host defense and immunity. This report describes the genomic organization and regulation of the human NLR family member NLRC5 and aspects of cellular function of the encoded protein. We have analyzed the tissue-specific expression of NLRC5 and have characterized regulatory elements in the NLRC5 promoter region that are responsive to IFN-gamma. We show that NLRC5 is upregulated in human fibroblasts postinfection with CMV and demonstrate the role of a JAK/STAT-mediated autocrine signaling loop involving IFN-gamma. We demonstrate that overexpression and enforced oligomerization of NLRC5 protein results in activation of the IFN-responsive regulatory promoter elements IFN-gamma activation sequence and IFN-specific response element and upregulation of antiviral target genes (e.g., IFN-alpha, OAS1, and PRKRIR). Finally, we demonstrate the effect of small interfering RNA-mediated knockdown of NLRC5 on a target gene level in the context of viral infection. We conclude that NLRC5 may represent a molecular switch of IFN-gamma activation sequence/IFN-specific response element signaling pathways contributing to antiviral defense mechanisms. Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular patterns or other cytosolic danger signals. Mutations in NLR genes have been linked to a variety of inflammatory diseases, underscoring their pivotal role in host defense and immunity. This report describes the genomic organization and regulation of the human NLR family member NLRC5 and aspects of cellular function of the encoded protein. We have analyzed the tissue-specific expression of NLRC5 and have characterized regulatory elements in the NLRC5 promoter region that are responsive to IFN-gamma. We show that NLRC5 is upregulated in human fibroblasts postinfection with CMV and demonstrate the role of a JAK/STAT-mediated autocrine signaling loop involving IFN-gamma. We demonstrate that overexpression and enforced oligomerization of NLRC5 protein results in activation of the IFN-responsive regulatory promoter elements IFN-gamma activation sequence and IFN-specific response element and upregulation of antiviral target genes (e.g., IFN-alpha, OAS1, and PRKRIR). Finally, we demonstrate the effect of small interfering RNA-mediated knockdown of NLRC5 on a target gene level in the context of viral infection. We conclude that NLRC5 may represent a molecular switch of IFN-gamma activation sequence/IFN-specific response element signaling pathways contributing to antiviral defense mechanisms.Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular patterns or other cytosolic danger signals. Mutations in NLR genes have been linked to a variety of inflammatory diseases, underscoring their pivotal role in host defense and immunity. This report describes the genomic organization and regulation of the human NLR family member NLRC5 and aspects of cellular function of the encoded protein. We have analyzed the tissue-specific expression of NLRC5 and have characterized regulatory elements in the NLRC5 promoter region that are responsive to IFN-gamma. We show that NLRC5 is upregulated in human fibroblasts postinfection with CMV and demonstrate the role of a JAK/STAT-mediated autocrine signaling loop involving IFN-gamma. We demonstrate that overexpression and enforced oligomerization of NLRC5 protein results in activation of the IFN-responsive regulatory promoter elements IFN-gamma activation sequence and IFN-specific response element and upregulation of antiviral target genes (e.g., IFN-alpha, OAS1, and PRKRIR). Finally, we demonstrate the effect of small interfering RNA-mediated knockdown of NLRC5 on a target gene level in the context of viral infection. We conclude that NLRC5 may represent a molecular switch of IFN-gamma activation sequence/IFN-specific response element signaling pathways contributing to antiviral defense mechanisms. Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular patterns or other cytosolic danger signals. Mutations in NLR genes have been linked to a variety of inflammatory diseases, underscoring their pivotal role in host defense and immunity. This report describes the genomic organization and regulation of the human NLR family member NLRC5 and aspects of cellular function of the encoded protein. We have analyzed the tissue-specific expression of NLRC5 and have characterized regulatory elements in the NLRC5 promoter region that are responsive to IFN-γ. We show that NLRC5 is upregulated in human fibroblasts postinfection with CMV and demonstrate the role of a JAK/STAT-mediated autocrine signaling loop involving IFN-γ. We demonstrate that overexpression and enforced oligomerization of NLRC5 protein results in activation of the IFN-responsive regulatory promoter elements IFN-γ activation sequence and IFN-specific response element and upregulation of antiviral target genes (e.g., IFN-α, OAS1, and PRKRIR). Finally, we demonstrate the effect of small interfering RNA-mediated knockdown of NLRC5 on a target gene level in the context of viral infection. We conclude that NLRC5 may represent a molecular switch of IFN-γ activation sequence/IFN-specific response element signaling pathways contributing to antiviral defense mechanisms. |
Author | Hasler, Robert Winkler, Michael Lipinski, Simone Schreiber, Stefan Fickenscher, Helmut Grotzinger, Joachim Rosenstiel, Philip Till, Andreas Kuenzel, Sven Jung, Sascha |
Author_xml | – sequence: 1 fullname: Kuenzel, Sven – sequence: 2 fullname: Till, Andreas – sequence: 3 fullname: Winkler, Michael – sequence: 4 fullname: Hasler, Robert – sequence: 5 fullname: Lipinski, Simone – sequence: 6 fullname: Jung, Sascha – sequence: 7 fullname: Grotzinger, Joachim – sequence: 8 fullname: Fickenscher, Helmut – sequence: 9 fullname: Schreiber, Stefan – sequence: 10 fullname: Rosenstiel, Philip |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20061403$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kb1v2zAUxIkiReOk3TsV3DopeRT1xTF1mkaA4QBBOhMs-WQzpUiVlGykf33lxl46dHpv-N3hcHdBznzwSMhHBlcFFOL62fb95IO7AgFQlvUbsmBlCVlVQXVGFgB5nrG6qs_JRUrPAFBBXrwj5_n8sQL4grw8bZGuJ-0wjNZg9sV6Y_2GPji7CT1G-1uNNnh6G3plfbayP5E-osZhDJGuV4_LkraJtn4X3A4NtZ62d-vsFgf0Bv1Ib_xodzYqR9tD1IM4DcEnTO_J2065hB-O95J8v_v6tLzPVg_f2uXNKtMFb8ZMg1GsE6LLuS5rXuYdMNGoirEOOiVMo1hV541G5I1quCiNUrkpAETXNVqV_JJ8fvUdYvg1YRplb5NG55THMCVZc94wqFk1k5-O5PSjRyOHaHsVX-SprRmoXgEdQ0oRO6nt-LefMSrrJAN5mEWeZpHHWWYh_CM8ef9Hcoy9tZvt3kaUqVfOzdGY3O_3rClkIZkQwP8ASgWgeQ |
CitedBy_id | crossref_primary_10_4049_jimmunol_1002227 crossref_primary_10_1038_s41467_024_52119_6 crossref_primary_10_1189_jlb_0312132 crossref_primary_10_2217_fmb_2023_0233 crossref_primary_10_1089_vim_2015_0130 crossref_primary_10_1515_med_2018_0066 crossref_primary_10_1016_j_isci_2023_106313 crossref_primary_10_1111_jfb_14871 crossref_primary_10_3389_fimmu_2024_1426620 crossref_primary_10_1073_pnas_1602069113 crossref_primary_10_1007_s13238_012_2109_3 crossref_primary_10_1016_j_virol_2010_12_015 crossref_primary_10_3390_ijms241914820 crossref_primary_10_3389_fimmu_2018_02314 crossref_primary_10_5812_gct_118882 crossref_primary_10_1016_j_cytogfr_2014_07_001 crossref_primary_10_1038_cddiscovery_2017_17 crossref_primary_10_3390_ijms22031301 crossref_primary_10_1016_j_tibs_2013_01_001 crossref_primary_10_1073_pnas_1611711113 crossref_primary_10_1128_jvi_00158_22 crossref_primary_10_3389_fimmu_2019_02648 crossref_primary_10_4049_jimmunol_1200064 crossref_primary_10_1111_1348_0421_12167 crossref_primary_10_1371_journal_pone_0123970 crossref_primary_10_1016_j_gene_2015_05_023 crossref_primary_10_1016_j_cytogfr_2012_09_003 crossref_primary_10_1038_s41467_019_08743_8 crossref_primary_10_1038_cr_2012_83 crossref_primary_10_3892_etm_2019_8309 crossref_primary_10_1016_j_yexcr_2015_11_021 crossref_primary_10_3892_mmr_2017_6990 crossref_primary_10_1016_j_biopha_2016_08_012 crossref_primary_10_1016_j_jaut_2011_01_002 crossref_primary_10_1089_ars_2013_5798 crossref_primary_10_1128_JVI_05738_11 crossref_primary_10_3389_fimmu_2023_1161606 crossref_primary_10_1152_physrev_00009_2014 crossref_primary_10_3389_fimmu_2018_00710 crossref_primary_10_1016_j_biopha_2017_07_132 crossref_primary_10_3109_08830185_2010_529976 crossref_primary_10_1186_s12964_023_01466_w crossref_primary_10_1016_j_jtho_2022_05_014 crossref_primary_10_1016_j_dci_2018_02_013 crossref_primary_10_1016_j_ejphar_2022_175051 crossref_primary_10_1016_j_fsi_2015_09_024 crossref_primary_10_1111_imm_13235 crossref_primary_10_1186_s40425_016_0143_z crossref_primary_10_1074_jbc_M112_364604 crossref_primary_10_3390_ijms18071530 crossref_primary_10_1186_1471_2105_14_275 crossref_primary_10_1016_j_tranon_2023_101742 crossref_primary_10_1111_jfd_12841 crossref_primary_10_1016_j_imbio_2017_01_001 crossref_primary_10_3390_ijms24108595 crossref_primary_10_1002_cbin_11565 crossref_primary_10_1016_j_dci_2016_08_017 crossref_primary_10_1007_s12026_016_8873_z crossref_primary_10_3389_fcvm_2024_1429858 crossref_primary_10_1080_15548627_2022_2126614 crossref_primary_10_1186_s12864_022_08647_w crossref_primary_10_1093_infdis_jiab254 crossref_primary_10_1186_s12974_023_02755_4 crossref_primary_10_3389_fimmu_2017_00150 crossref_primary_10_1016_j_mam_2020_100887 crossref_primary_10_3390_cells12141882 crossref_primary_10_1016_j_gene_2016_10_026 crossref_primary_10_1111_jnc_14876 crossref_primary_10_3390_cells9081857 crossref_primary_10_1016_j_coi_2010_12_003 crossref_primary_10_1016_j_chom_2024_08_013 crossref_primary_10_3390_v15112227 crossref_primary_10_1038_ni_1985 crossref_primary_10_4049_jimmunol_1102671 crossref_primary_10_1002_biof_1285 crossref_primary_10_1007_s00018_024_05369_y crossref_primary_10_1084_jem_20151531 crossref_primary_10_1038_nri2851 crossref_primary_10_1016_j_biocel_2015_11_010 crossref_primary_10_12688_f1000research_12517_1 crossref_primary_10_1038_s41598_021_82729_9 crossref_primary_10_1016_j_bbi_2019_03_011 crossref_primary_10_1111_age_12450 crossref_primary_10_1371_journal_pone_0092704 crossref_primary_10_4049_jimmunol_1003111 crossref_primary_10_1165_rcmb_2010_0288OC crossref_primary_10_1146_annurev_immunol_031210_101405 crossref_primary_10_3389_fimmu_2024_1355012 crossref_primary_10_1016_j_molimm_2017_12_005 crossref_primary_10_1002_bies_202300109 crossref_primary_10_3389_fphar_2019_01352 crossref_primary_10_1371_journal_pone_0133450 crossref_primary_10_3390_v16071110 crossref_primary_10_3390_v2112541 crossref_primary_10_1128_JVI_00349_15 crossref_primary_10_3390_ijms22041964 crossref_primary_10_1002_eji_201344412 crossref_primary_10_3390_vaccines10091487 crossref_primary_10_3389_fcimb_2020_00230 crossref_primary_10_1016_j_canlet_2016_03_006 crossref_primary_10_1016_j_molimm_2011_02_002 crossref_primary_10_4049_jimmunol_1002094 crossref_primary_10_1016_j_bj_2023_100637 crossref_primary_10_1016_j_vetimm_2019_109992 crossref_primary_10_1186_1297_9716_44_82 crossref_primary_10_1016_j_coi_2011_07_005 crossref_primary_10_1016_j_taap_2016_01_012 crossref_primary_10_1016_j_jmb_2013_08_023 crossref_primary_10_1080_14728222_2023_2248377 crossref_primary_10_1038_srep20295 crossref_primary_10_1128_IAI_00876_18 crossref_primary_10_1016_j_immuni_2011_03_026 crossref_primary_10_4049_jimmunol_0903900 crossref_primary_10_1128_JVI_00377_17 crossref_primary_10_1093_jpids_piaa048 crossref_primary_10_1016_j_dci_2020_103977 crossref_primary_10_1096_fj_201700511RR crossref_primary_10_1371_journal_pone_0146636 crossref_primary_10_1016_j_bbrc_2011_08_127 crossref_primary_10_3389_fimmu_2021_704989 crossref_primary_10_1186_s13148_024_01698_8 crossref_primary_10_1016_j_dci_2016_11_018 crossref_primary_10_1186_s12964_024_02012_y crossref_primary_10_1007_s00432_021_03601_x crossref_primary_10_1007_s10753_013_9804_y crossref_primary_10_1111_imm_12989 crossref_primary_10_1007_s00251_019_01106_z crossref_primary_10_1146_annurev_immunol_101320_031555 crossref_primary_10_1016_j_meegid_2016_07_013 crossref_primary_10_1038_s42003_025_07755_z crossref_primary_10_1111_imr_12089 crossref_primary_10_1016_j_imbio_2011_08_011 crossref_primary_10_3390_ijms241713265 crossref_primary_10_3389_fmed_2021_661076 crossref_primary_10_1007_s11033_020_05253_5 crossref_primary_10_1164_rccm_201707_1391PP crossref_primary_10_1016_j_canlet_2019_03_005 crossref_primary_10_1073_pnas_1008684107 crossref_primary_10_1128_JVI_01297_15 crossref_primary_10_1074_jbc_M110_109736 crossref_primary_10_1128_microbiolspec_MCHD_0021_2015 crossref_primary_10_4049_jimmunol_1103136 crossref_primary_10_1016_j_immuni_2011_05_007 crossref_primary_10_1053_j_gastro_2020_03_009 crossref_primary_10_1093_infdis_jiz512 crossref_primary_10_1126_sciadv_abn5732 crossref_primary_10_1007_s12026_019_09111_w crossref_primary_10_1016_j_ijbiomac_2020_12_127 crossref_primary_10_1016_j_micinf_2011_12_007 crossref_primary_10_3390_ijms22094677 crossref_primary_10_1021_bi500177x crossref_primary_10_1080_2162402X_2016_1151593 crossref_primary_10_1038_nri3339 crossref_primary_10_3390_cancers12071760 crossref_primary_10_1038_cr_2012_56 crossref_primary_10_1038_cr_2012_53 crossref_primary_10_1186_1746_6148_8_23 crossref_primary_10_1002_brb3_72 |
Cites_doi | 10.1056/NEJMoa061592 10.1128/JVI.79.5.3084-3096.2005 10.4049/jimmunol.179.8.5425 10.1006/meth.2001.1262 10.1038/ng.285 10.1074/jbc.M003415200 10.1074/jbc.R700016200 10.1074/jbc.M008072200 10.1053/gast.2003.50019 10.1146/annurev.immunol.23.021704.115616 10.1002/art.10688 10.1084/jem.20081667 10.1038/ng720 10.1093/embo-reports/kve155 10.1002/art.10618 10.1086/341357 10.1038/nature04516 10.1038/nri1604 10.1016/j.cyto.2008.07.013 10.1186/ar2525 10.1038/ng1101-241 10.1038/35079107 10.1038/nri1226 10.1038/ng756 10.1128/MCB.18.2.859 10.1038/ni945 10.1038/nri1086 10.1111/j.1600-065X.2008.00734.x 10.1038/nri888 10.1002/art.10509 10.1074/jbc.274.21.14560 10.1016/S0140-6736(00)05063-7 10.1242/jcs.016980 10.1016/j.clim.2005.02.007 10.1038/sj.onc.1204787 10.1046/j.1365-2443.1996.870287.x 10.1038/35079114 10.1128/JVI.74.17.7720-7729.2000 10.1016/j.bbrc.2005.10.074 10.1016/j.it.2006.06.003 10.1038/nature06501 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.4049/jimmunol.0900557 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 2000 |
ExternalDocumentID | 20061403 10_4049_jimmunol_0900557 www184_4_1990 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS 79B 85S 8RP AALRV AARDX ABFLS ABOCM ABPPZ ABPTK ACGFS ACIWK ACNCT ACPRK ADACO ADBBV AENEX AETEA AFFNX AFRAH AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL D0L DIK DU5 E3Z EBS EJD F5P FH7 FRP GX1 H13 IH2 K-O K78 KQ8 L7B O0- OK1 P0W P2P PQEST PQQKQ R.V RHF RHI RZQ SJN TWZ WH7 WOQ X X7M XJT ZA5 ZE2 ZGI --- -~X .55 0R~ 18M 5WD AAYXX ABCQX ABDFA ABEJV ABGNP ABJNI ABXVV ACGFO ADIPN ADNWM AFHIN AFOSN AGORE AHMMS AHWXS AIZAD ARBBW BCRHZ BTFSW CITATION OCZFY OWPYF ROX TR2 W8F XSW XTH YHG CGR CUY CVF ECM EIF NPM 7X8 KOP |
ID | FETCH-LOGICAL-c438t-c0da1f99f23c57352f0198a611f0fa9d8a16728cee38a8395daa2d4009ff8ca53 |
ISSN | 0022-1767 1550-6606 |
IngestDate | Thu Sep 04 16:32:37 EDT 2025 Thu Apr 03 06:53:12 EDT 2025 Thu Apr 24 22:50:12 EDT 2025 Tue Jul 01 04:32:54 EDT 2025 Tue Nov 10 19:47:55 EST 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c438t-c0da1f99f23c57352f0198a611f0fa9d8a16728cee38a8395daa2d4009ff8ca53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/184/4/1990/1318143/ji_0900557.pdf |
PMID | 20061403 |
PQID | 733810716 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_733810716 pubmed_primary_20061403 crossref_citationtrail_10_4049_jimmunol_0900557 crossref_primary_10_4049_jimmunol_0900557 highwire_smallpub1_www184_4_1990 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-02-15 |
PublicationDateYYYYMMDD | 2010-02-15 |
PublicationDate_xml | – month: 02 year: 2010 text: 2010-02-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2010 |
Publisher | Am Assoc Immnol |
Publisher_xml | – name: Am Assoc Immnol |
References | Martinon (2022123119575468200_r35) 2006; 440 Ichinohe (2022123119575468200_r43) 2009; 206 Ogura (2022123119575468200_r27) 2001; 276 Gale (2022123119575468200_r37) 1998; 18 Shuai (2022123119575468200_r23) 2003; 3 Ting (2022123119575468200_r5) 2005; 115 Inohara (2022123119575468200_r2) 2003; 3 Franchi (2022123119575468200_r4) 2009; 227 Chamaillard (2022123119575468200_r39) 2003; 4 Girardin (2022123119575468200_r28) 2001; 2 Schierling (2022123119575468200_r18) 2005; 79 Schindler (2022123119575468200_r22) 2007; 282 Villani (2022123119575468200_r14) 2009; 41 Albrecht (2022123119575468200_r21) 2006; 339 Jin (2022123119575468200_r15) 2007; 356 Till (2022123119575468200_r16) 2008; 121 Harada (2022123119575468200_r36) 1996; 1 Aksentijevich (2022123119575468200_r32) 2002; 46 Bonen (2022123119575468200_r40) 2003; 124 Ting (2022123119575468200_r1) 2005; 23 Hugot (2022123119575468200_r7) 2001; 411 Hampe (2022123119575468200_r9) 2001; 357 Miceli-Richard (2022123119575468200_r10) 2001; 29 Hoffman (2022123119575468200_r12) 2001; 29 Benko (2022123119575468200_r34) 2008; 43 Aganna (2022123119575468200_r31) 2002; 46 Mathews (2022123119575468200_r33) 2008; 10 Wang (2022123119575468200_r30) 2002; 46 Creagh (2022123119575468200_r6) 2006; 27 Platanias (2022123119575468200_r24) 2005; 5 Chen (2022123119575468200_r29) 2009 Ogura (2022123119575468200_r8) 2001; 411 Hirata (2022123119575468200_r19) 2007; 179 Tattoli (2022123119575468200_r42) 2008 Kastner (2022123119575468200_r11) 2001; 29 Katze (2022123119575468200_r25) 2002; 2 Livak (2022123119575468200_r20) 2001; 25 Inohara (2022123119575468200_r3) 2000; 275 Inohara (2022123119575468200_r26) 1999; 274 Hobom (2022123119575468200_r17) 2000; 74 Feldmann (2022123119575468200_r13) 2002; 71 Inohara (2022123119575468200_r38) 2001; 20 Moore (2022123119575468200_r41) 2008; 451 |
References_xml | – volume: 356 start-page: 1216 year: 2007 ident: 2022123119575468200_r15 article-title: NALP1 in vitiligo-associated multiple autoimmune disease. publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa061592 – volume: 79 start-page: 3084 year: 2005 ident: 2022123119575468200_r18 article-title: Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. publication-title: J. Virol. doi: 10.1128/JVI.79.5.3084-3096.2005 – volume: 179 start-page: 5425 year: 2007 ident: 2022123119575468200_r19 article-title: Activation of innate immune defense mechanisms by signaling through RIG-I/IPS-1 in intestinal epithelial cells. publication-title: J. Immunol. doi: 10.4049/jimmunol.179.8.5425 – volume: 25 start-page: 402 year: 2001 ident: 2022123119575468200_r20 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 41 start-page: 71 year: 2009 ident: 2022123119575468200_r14 article-title: Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility. publication-title: Nat. Genet. doi: 10.1038/ng.285 – volume: 275 start-page: 27823 year: 2000 ident: 2022123119575468200_r3 article-title: An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. publication-title: J. Biol. Chem. doi: 10.1074/jbc.M003415200 – volume: 282 start-page: 20059 year: 2007 ident: 2022123119575468200_r22 article-title: JAK-STAT signaling: from interferons to cytokines. publication-title: J. Biol. Chem. doi: 10.1074/jbc.R700016200 – volume: 276 start-page: 4812 year: 2001 ident: 2022123119575468200_r27 article-title: Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. publication-title: J. Biol. Chem. doi: 10.1074/jbc.M008072200 – volume: 124 start-page: 140 year: 2003 ident: 2022123119575468200_r40 article-title: Crohn’s disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. publication-title: Gastroenterology doi: 10.1053/gast.2003.50019 – volume: 23 start-page: 387 year: 2005 ident: 2022123119575468200_r1 article-title: CATERPILLER: a novel gene family important in immunity, cell death, and diseases. publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.23.021704.115616 – volume: 46 start-page: 3340 year: 2002 ident: 2022123119575468200_r32 article-title: De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. publication-title: Arthritis Rheum. doi: 10.1002/art.10688 – volume: 206 start-page: 79 year: 2009 ident: 2022123119575468200_r43 article-title: Inflammasome recognition of influenza virus is essential for adaptive immune responses. publication-title: J. Exp. Med. doi: 10.1084/jem.20081667 – volume: 29 start-page: 19 year: 2001 ident: 2022123119575468200_r10 article-title: CARD15 mutations in Blau syndrome. publication-title: Nat. Genet. doi: 10.1038/ng720 – volume: 2 start-page: 736 year: 2001 ident: 2022123119575468200_r28 article-title: CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. publication-title: EMBO Rep. doi: 10.1093/embo-reports/kve155 – volume: 46 start-page: 3041 year: 2002 ident: 2022123119575468200_r30 article-title: CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. publication-title: Arthritis Rheum. doi: 10.1002/art.10618 – volume: 71 start-page: 198 year: 2002 ident: 2022123119575468200_r13 article-title: Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. publication-title: Am. J. Hum. Genet. doi: 10.1086/341357 – volume: 440 start-page: 237 year: 2006 ident: 2022123119575468200_r35 article-title: Gout-associated uric acid crystals activate the NALP3 inflammasome. publication-title: Nature doi: 10.1038/nature04516 – volume: 5 start-page: 375 year: 2005 ident: 2022123119575468200_r24 article-title: Mechanisms of type-I- and type-II-interferon-mediated signalling. publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1604 – volume: 43 start-page: 368 year: 2008 ident: 2022123119575468200_r34 article-title: The microbial and danger signals that activate Nod-like receptors. publication-title: Cytokine doi: 10.1016/j.cyto.2008.07.013 – volume: 10 start-page: 228 year: 2008 ident: 2022123119575468200_r33 article-title: NOD-like receptors and inflammation. publication-title: Arthritis Res. Ther. doi: 10.1186/ar2525 – volume: 29 start-page: 241 year: 2001 ident: 2022123119575468200_r11 article-title: A fever gene comes in from the cold. publication-title: Nat. Genet. doi: 10.1038/ng1101-241 – volume: 411 start-page: 599 year: 2001 ident: 2022123119575468200_r7 article-title: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. publication-title: Nature doi: 10.1038/35079107 – volume: 3 start-page: 900 year: 2003 ident: 2022123119575468200_r23 article-title: Regulation of JAK-STAT signalling in the immune system. publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1226 – volume: 29 start-page: 301 year: 2001 ident: 2022123119575468200_r12 article-title: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. publication-title: Nat. Genet. doi: 10.1038/ng756 – volume: 18 start-page: 859 year: 1998 ident: 2022123119575468200_r37 article-title: Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK. publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.18.2.859 – volume: 4 start-page: 702 year: 2003 ident: 2022123119575468200_r39 article-title: An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. publication-title: Nat. Immunol. doi: 10.1038/ni945 – volume: 3 start-page: 371 year: 2003 ident: 2022123119575468200_r2 article-title: NODs: intracellular proteins involved in inflammation and apoptosis. publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1086 – volume: 227 start-page: 106 year: 2009 ident: 2022123119575468200_r4 article-title: Function of Nod-like receptors in microbial recognition and host defense. publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00734.x – volume: 2 start-page: 675 year: 2002 ident: 2022123119575468200_r25 article-title: Viruses and interferon: a fight for supremacy publication-title: Nat. Rev. Immunol. doi: 10.1038/nri888 – volume: 46 start-page: 2445 year: 2002 ident: 2022123119575468200_r31 article-title: Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. publication-title: Arthritis Rheum. doi: 10.1002/art.10509 – volume: 274 start-page: 14560 year: 1999 ident: 2022123119575468200_r26 article-title: Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.21.14560 – volume: 357 start-page: 1925 year: 2001 ident: 2022123119575468200_r9 article-title: Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. publication-title: Lancet doi: 10.1016/S0140-6736(00)05063-7 – start-page: 365 volume-title: Annu. Rev. Pathol. year: 2009 ident: 2022123119575468200_r29 article-title: NOD-like receptors: role in innate immunity and inflammatory disease. – volume: 121 start-page: 487 year: 2008 ident: 2022123119575468200_r16 article-title: A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion. publication-title: J. Cell Sci. doi: 10.1242/jcs.016980 – start-page: 293 volume-title: EMBO Rep. year: 2008 ident: 2022123119575468200_r42 article-title: NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. – volume: 115 start-page: 33 year: 2005 ident: 2022123119575468200_r5 article-title: The CATERPILLER family: an ancient family of immune/apoptotic proteins. publication-title: Clin. Immunol. doi: 10.1016/j.clim.2005.02.007 – volume: 20 start-page: 6473 year: 2001 ident: 2022123119575468200_r38 article-title: The NOD: a signaling module that regulates apoptosis and host defense against pathogens. publication-title: Oncogene doi: 10.1038/sj.onc.1204787 – volume: 1 start-page: 995 year: 1996 ident: 2022123119575468200_r36 article-title: Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta. publication-title: Genes Cells doi: 10.1046/j.1365-2443.1996.870287.x – volume: 411 start-page: 603 year: 2001 ident: 2022123119575468200_r8 article-title: A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. publication-title: Nature doi: 10.1038/35079114 – volume: 74 start-page: 7720 year: 2000 ident: 2022123119575468200_r17 article-title: Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. publication-title: J. Virol. doi: 10.1128/JVI.74.17.7720-7729.2000 – volume: 339 start-page: 459 year: 2006 ident: 2022123119575468200_r21 article-title: Update on the domain architectures of NLRs and R proteins. publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.10.074 – volume: 27 start-page: 352 year: 2006 ident: 2022123119575468200_r6 article-title: TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. publication-title: Trends Immunol. doi: 10.1016/j.it.2006.06.003 – volume: 451 start-page: 573 year: 2008 ident: 2022123119575468200_r41 article-title: NLRX1 is a regulator of mitochondrial antiviral immunity. publication-title: Nature doi: 10.1038/nature06501 |
SSID | ssj0006024 |
Score | 2.4146793 |
Snippet | Nucleotide-binding oligomerization domain-like receptors (NLRs) are a group of intracellular proteins that mediate recognition of pathogen-associated molecular... |
SourceID | proquest pubmed crossref highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1990 |
SubjectTerms | Amino Acid Sequence Caco-2 Cells Cell Line, Tumor Cells, Cultured Cytomegalovirus - immunology Fibroblasts - immunology Fibroblasts - virology HeLa Cells HT29 Cells Humans Interferon-gamma - chemistry Interferon-gamma - metabolism Interferon-gamma - physiology Intracellular Signaling Peptides and Proteins - genetics Intracellular Signaling Peptides and Proteins - isolation & purification Intracellular Signaling Peptides and Proteins - physiology Molecular Sequence Data Oligodeoxyribonucleotides - genetics Oligodeoxyribonucleotides - metabolism Protein Binding - immunology Protein Structure, Tertiary - genetics Response Elements - immunology Signal Transduction - immunology |
Title | The Nucleotide-Binding Oligomerization Domain-Like Receptor NLRC5 Is Involved in IFN-Dependent Antiviral Immune Responses |
URI | http://www.jimmunol.org/cgi/content/abstract/184/4/1990 https://www.ncbi.nlm.nih.gov/pubmed/20061403 https://www.proquest.com/docview/733810716 |
Volume | 184 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBANGuckP8ICqdHHiJM4jDKaVbUWCTewtchIHBbIErekq9uP4bZwTO2laNsR4iarIcd18X33O8bkR8jLmLFXKZ5Yfx8riIfp3vVRYSoiYZa6MvSY9-nDq7x3zDyfeyWDwqxe1NK_jcXJxaV7J_6AK9wBXzJK9BrLdpHADPgO-cAWE4frPGE-xIHFV56my3uY6ReVjkX-t0BOjUyxBST4F-986yL9jkwaMY6nORtODTzveaDLDShtVca6wBtNosju13pm2uDUWFsgxBrgYTTCLBB9uAmpN2OG35SJ6am2OQ3Vhp1eN-8zuHTbsz1V5oeMCPp-rXgywdn400ZWy0_K_gJ1sEhX70f1Iwsa_z2dt5-YmPLx_gIG-d8fSKZy9hAIW6K4cY2X2YQ-sWt_2Vzdq3mMk7227LNQ9R40Ix_Sjy8QDB3MIxYN5E2M7bEqQLUVh6_5fk5Bd3CJYTDhH1M4QmRlukJtOALobKuWT_U4T8G2Ht9Xq8QdqNznOsL2-hlW1qC1VfbXZ06g_R_fIXQMwfaNJeJ8MVLlJbulOpj83ye1DE6PxgGArRPonK-kaK2mPlbRlJW1YSScz2rKS5iVdYSXtWEk1K2nHyofkePf90c6eZRp8WAl3RW0ldipZFoaZ4yZeAKZABgaHkD5jmZ3JMBWS-YEjQI9zhQRN3kuldFKQOmGWiUR67iOyUValekwoKK6ZVEx6Afe5nanQVjyEXUiFwhaxEw_Jdvt-o8RUv8cmLEV0FaZD8rp74oeu_PKXsbSFLJqdyqIAqFi0WCyAshGPkJ4wpIUygh0c3XKyVNV8FgUuVtkLmD8kWxri7vvwvA8Laj65xlqekjvLf9kzslGfzdVzUJzr-EXDzt_klMV_ |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Nucleotide-Binding+Oligomerization+Domain-Like+Receptor+NLRC5+Is+Involved+in+IFN-Dependent+Antiviral+Immune+Responses&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Kuenzel%2C+Sven&rft.au=Till%2C+Andreas&rft.au=Winkler%2C+Michael&rft.au=H%C3%A4sler%2C+Robert&rft.date=2010-02-15&rft.issn=0022-1767&rft.eissn=1550-6606&rft.volume=184&rft.issue=4&rft.spage=1990&rft.epage=2000&rft_id=info:doi/10.4049%2Fjimmunol.0900557&rft.externalDBID=n%2Fa&rft.externalDocID=10_4049_jimmunol_0900557 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |